GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Medical Services Holdings Ltd (NYSE:CCM) » Definitions » Enterprise Value

Concord Medical Services Holdings (Concord Medical Services Holdings) Enterprise Value : $1,024.81 Mil (As of Apr. 29, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Concord Medical Services Holdings Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Concord Medical Services Holdings's Enterprise Value is $1,024.81 Mil. Concord Medical Services Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-54.55 Mil. Therefore, Concord Medical Services Holdings's EV-to-EBIT ratio for today is -18.79.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Concord Medical Services Holdings's Enterprise Value is $1,024.81 Mil. Concord Medical Services Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-54.55 Mil. Therefore, Concord Medical Services Holdings's EV-to-EBITDA ratio for today is -18.79.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Concord Medical Services Holdings's Enterprise Value is $1,024.81 Mil. Concord Medical Services Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $75.15 Mil. Therefore, Concord Medical Services Holdings's EV-to-Revenue ratio for today is 13.64.


Concord Medical Services Holdings Enterprise Value Historical Data

The historical data trend for Concord Medical Services Holdings's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Medical Services Holdings Enterprise Value Chart

Concord Medical Services Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 656.23 896.35 1,137.05 1,069.70 1,043.04

Concord Medical Services Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,137.05 1,130.97 1,069.70 1,034.08 1,043.04

Competitive Comparison of Concord Medical Services Holdings's Enterprise Value

For the Medical Care Facilities subindustry, Concord Medical Services Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Medical Services Holdings's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Concord Medical Services Holdings's Enterprise Value falls into.



Concord Medical Services Holdings Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Concord Medical Services Holdings's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Concord Medical Services Holdings's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Medical Services Holdings  (NYSE:CCM) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Concord Medical Services Holdings's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1024.806/-54.548
=-18.79

Concord Medical Services Holdings's current Enterprise Value is $1,024.81 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Concord Medical Services Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-54.55 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Concord Medical Services Holdings's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1024.806/-54.548
=-18.79

Concord Medical Services Holdings's current Enterprise Value is $1,024.81 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Concord Medical Services Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-54.55 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Concord Medical Services Holdings's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1024.806/75.147
=13.64

Concord Medical Services Holdings's current Enterprise Value is $1,024.81 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Concord Medical Services Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $75.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Medical Services Holdings Enterprise Value Related Terms

Thank you for viewing the detailed overview of Concord Medical Services Holdings's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Medical Services Holdings (Concord Medical Services Holdings) Business Description

Traded in Other Exchanges
N/A
Address
Room 2701-05 , 36 North Third Ring Road, Tower A, Global Trade Center, Dongcheng District, Beijing, CHN, 100013
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers and diagnostic imaging centers and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.